NewsRx

Search our medical news database

Johnson & Johnson

Johnson & Johnson has provided details on its latest developments

Published in Physician Law Weekly, January 24th, 2007

Johnson & Johnson has provided details on its latest developments.

This trend article is an immediate alert from NewsRx to identify the most recent news developments at Johnson & Johnson.

Report 1: Johnson & Johnson (JNJ) and Conor Medsystems, Inc., (CONR), a cardiovascular device company, announced a definitive agreement whereby Johnson & Johnson will acquire Conor Medsystems for approximately $1.4 billion.

The acquisition of Conor Medsystems by Johnson & Johnson will provide Cordis Corp., a Johnson & Johnson company, with a unique controlled drug-delivery technology. This technology is currently employed on the CoStar Stent...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Physician Law Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook